Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of Endocrinological Investigation
|
October 30, 2017
How to improve effectiveness of pegvisomant treatment in acromegalic patients
M Ragonese, S Grottoli, P Maffei, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2008
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas
A Fusco, M C Zatelli, A Bianchi, et al.
Journal of Endocrinological Investigation
|
February 20, 2024
Transition from pediatric to adult care in patients with Turner syndrome in Italy: a consensus statement by the TRAMITI project
T Aversa, L De Sanctis, M F Faienza, et al.
ESMO Open
|
May 13, 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
N Silvestris, A Argentiero, A Natalicchio, et al.
ESMO Open
|
May 21, 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
M Gallo, V Adinolfi, L Morviducci, et al.
European Journal of Endocrinology
|
February 16, 2020
Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study
A Veltroni, E Cosaro, F Spada, et al.
ESMO Open
|
June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, M Montagnani, M Gallo, et al.
Journal of Endocrinological Investigation
|
August 18, 2020
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
F Panzuto, M Maccauro, D Campana, et al.
ESMO Open
|
December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
N Silvestris, T Franchina, M Gallo, et al.
Journal of Endocrinological Investigation
|
June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, N Marrano, M Montagnani, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of Endocrinological Investigation
|
October 30, 2017
How to improve effectiveness of pegvisomant treatment in acromegalic patients
M Ragonese, S Grottoli, P Maffei, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 8, 2008
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas
A Fusco, M C Zatelli, A Bianchi, et al.
Journal of Endocrinological Investigation
|
February 20, 2024
Transition from pediatric to adult care in patients with Turner syndrome in Italy: a consensus statement by the TRAMITI project
T Aversa, L De Sanctis, M F Faienza, et al.
ESMO Open
|
May 13, 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
N Silvestris, A Argentiero, A Natalicchio, et al.
ESMO Open
|
May 21, 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
M Gallo, V Adinolfi, L Morviducci, et al.
European Journal of Endocrinology
|
February 16, 2020
Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study
A Veltroni, E Cosaro, F Spada, et al.
ESMO Open
|
June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, M Montagnani, M Gallo, et al.
Journal of Endocrinological Investigation
|
August 18, 2020
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
F Panzuto, M Maccauro, D Campana, et al.
ESMO Open
|
December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
N Silvestris, T Franchina, M Gallo, et al.
Journal of Endocrinological Investigation
|
June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, N Marrano, M Montagnani, et al.
Page
of 5